SpaceX rocket to launch South Korea’s first military satellite
By Nikita Chaurasia  Date: 2020-07-13

SpaceX rocket to launch South Korea’s first military satellite

The SpaceX rocket which kick started company’s astronaut mission last month has reportedly once again fired its engines in a bid to set the stage for launching first Korean military satellite this week.

If reports are to be believed, the launch of Anasis-II communications satellite for military is planned on Tuesday (14th July) at 5 p.m. EDT (17:00 GMT).

Speaking of the move, SpaceX tweeted that the static fire test is completed, Falcon 9 launch of the ANASIS-II is planned on 14th July from SLC-40 located in Florida. They further added that NASA astronauts Doug Hurley and Bob Behnken were launched by Falcon 9 to International Space Station on SpaceX’s first crewed spaceflight Demo-2, on 30 May.

The rocket test happened as planned SpaceX launch of a distinct Falcon 9 rocket which carried two BlackSky Global Earth-imaging and 57 Starlink internet satellites from its nearby launch site Pad 39A at NASA Space Center, Kennedy. The test was called off by SpaceX on Saturday morning due to the necessity for more rocket checks.

As per Airbus, Anasis-II, fabricated by Airbus Defence and Space, is Korea’s first-ever military satellite designed with the intention to offer secured communications over a broad area. The satellite is built based on Eurostar E3000 satellite platform of Airbus and will be introduced into a geostationary orbit. These orbits enable satellites to retain its position over the Earth at an elevation of 22,000 miles (36,000 kms).

Spaceflight Now cites that Anasis-II was originally known as KMilSatCom. South Korea depended on international and civilian-owned satellites for communications needs, before this mission.

Source- https://www.space.com/spacex-test-fires-rocket-for-korean-military-satellite-anasis-2.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Borqs Technologies introduces BeSmartTrack™ for tracing COVID-19 virus
Borqs Technologies introduces BeSmartTrack™ for tracing COVID-19 virus
By Nikita Chaurasia

Lately, China-based leading developer of software application for IoT (Internet of Things) Borqs Technologies Inc. has gained significant attention upon launching its mobile smart tracking solution called BeSmartTrack™. The launch event reporte...

Fractyl raises series E funding of USD 55 million for diabetes cure
Fractyl raises series E funding of USD 55 million for diabetes cure
By Nikita Chaurasia

Fractyl Laboratories raised series E funding of USD 55 million to continue financing the pivotal clinical trial of its potential non-surgical, non-drug treatment for Type 2 diabetes. As per the trusted sources, the capital will be invested on mass-b...

Nokia Corp. partners with IISc to improve telecommunication solutions
Nokia Corp. partners with IISc to improve telecommunication solutions
By Nikita Chaurasia

Finnish multinational telecommunications giant Nokia Corporation has recently made it to the headlines after entering into a joint venture agreement with IISc (Indian Institute of Science) to launch the Nokia CoE (Centre of excellence) for Networked ...

Motorola acquires Pelco Inc. to expand its video security services
Motorola acquires Pelco Inc. to expand its video security services
By Nikita Chaurasia

Chicago-based telecommunication company, Motorola Solutions Inc., has made it to the headlines through its acquisition of Pelco Inc. from Transom Capital Group for $110 million dollars. For those uninitiated, Pelco Inc. is a security and surveillanc...

NeuroRx, Relief Therapeutics declare results of RLF-100 clinical trials
NeuroRx, Relief Therapeutics declare results of RLF-100 clinical trials
By Nikita Chaurasia

U.S.-based pharmaceutical company NeuroRx Inc., along with Relief Therapeutics Holding AG, a Swiss drug development company, have reportedly declared that aviptadil (RLF-100) clinical trials have showcased quick recuperation of respiratory failures a...